[Bounderies of the authorization to market and the therapeutic impass]. [electronic resource]
Producer: 20010906Description: 507-8 p. digitalISSN:- 0750-7658
- Anticoagulants -- adverse effects
- Chondroitin Sulfates -- adverse effects
- Dermatan Sulfate -- adverse effects
- Drug Approval -- legislation & jurisprudence
- Drug Combinations
- France
- Heparin -- adverse effects
- Heparitin Sulfate -- adverse effects
- Hirudin Therapy
- Hirudins -- adverse effects
- Humans
- Recombinant Proteins -- adverse effects
No physical items for this record
Publication Type: Editorial
There are no comments on this title.
Log in to your account to post a comment.